143 related articles for article (PubMed ID: 17157196)
1. Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice.
Cuzzocrea S; Mazzon E; Genovese T; Crisafulli C; Min WK; Di Paola R; Muià C; Li JH; Malleo G; Xu W; Massuda E; Esposito E; Zhang J; Wang ZQ
Free Radic Biol Med; 2007 Jan; 42(1):90-105. PubMed ID: 17157196
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin reduces the development of experimental inflammatory bowel disease.
Cuzzocrea S; Mazzon E; Di Paola R; Patel NS; Genovese T; Muià C; De Sarro A; Thiemermann C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1272-80. PubMed ID: 15302898
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma.
Cuzzocrea S; Genovese T; Mazzon E; Crisafulli C; Min W; Di Paola R; Muià C; Li JH; Esposito E; Bramanti P; Xu W; Massuda E; Zhang J; Wang ZQ
J Pharmacol Exp Ther; 2006 Oct; 319(1):127-38. PubMed ID: 16825529
[TBL] [Abstract][Full Text] [Related]
5. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury.
Patel NS; Cortes U; Di Poala R; Mazzon E; Mota-Filipe H; Cuzzocrea S; Wang ZQ; Thiemermann C
J Am Soc Nephrol; 2005 Mar; 16(3):712-9. PubMed ID: 15677308
[TBL] [Abstract][Full Text] [Related]
7. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion.
Cuzzocrea S; Di Paola R; Mazzon E; Cortes U; Genovese T; Muià C; Li W; Xu W; Li JH; Zhang J; Wang ZQ
FASEB J; 2005 Apr; 19(6):558-66. PubMed ID: 15791006
[TBL] [Abstract][Full Text] [Related]
8. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) glycohydrolase as a target for neuroprotective intervention: assessment of currently available pharmacological tools.
Falsig J; Christiansen SH; Feuerhahn S; Bürkle A; Oei SL; Keil C; Leist M
Eur J Pharmacol; 2004 Aug; 497(1):7-16. PubMed ID: 15321729
[TBL] [Abstract][Full Text] [Related]
10. Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice.
Genovese T; Di Paola R; Catalano P; Li JH; Xu W; Massuda E; Caputi AP; Zhang J; Cuzzocrea S
Crit Care Med; 2004 Jun; 32(6):1365-74. PubMed ID: 15187521
[TBL] [Abstract][Full Text] [Related]
11. A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Oct; 333(2):256-64. PubMed ID: 15450800
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S
Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708
[TBL] [Abstract][Full Text] [Related]
13. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
Impellizzeri D; Bruschetta G; Di Paola R; Ahmad A; Campolo M; Cuzzocrea S; Esposito E; Navarra M
Clin Nutr; 2015 Dec; 34(6):1146-54. PubMed ID: 25491246
[TBL] [Abstract][Full Text] [Related]
14. 5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis.
Mazzon E; Sautebin L; Caputi AP; Cuzzocrea S
Shock; 2006 Apr; 25(4):377-83. PubMed ID: 16670640
[TBL] [Abstract][Full Text] [Related]
15. Poly(etheno ADP-ribose) blocks poly(ADP-ribose) glycohydrolase activity.
Shirato M; Tozawa S; Maeda D; Watanabe M; Nakagama H; Masutani M
Biochem Biophys Res Commun; 2007 Apr; 355(2):451-6. PubMed ID: 17306228
[TBL] [Abstract][Full Text] [Related]
16. Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis.
Mazzon E; Cuzzocrea S
Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):45-57. PubMed ID: 12839336
[TBL] [Abstract][Full Text] [Related]
17. Altered DNA damage response in Caenorhabditis elegans with impaired poly(ADP-ribose) glycohydrolases genes expression.
St-Laurent JF; Gagnon SN; Dequen F; Hardy I; Desnoyers S
DNA Repair (Amst); 2007 Mar; 6(3):329-43. PubMed ID: 17188026
[TBL] [Abstract][Full Text] [Related]
18. Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus.
Ghia JE; Galeazzi F; Ford DC; Hogaboam CM; Vallance BA; Collins S
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G770-7. PubMed ID: 18202111
[TBL] [Abstract][Full Text] [Related]
19. Role of poly(ADP-ribose) glycohydrolase (PARG) in shock, ischemia and reperfusion.
Cuzzocrea S; Wang ZQ
Pharmacol Res; 2005 Jul; 52(1):100-8. PubMed ID: 15911338
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.
Antonioli L; Fornai M; Colucci R; Ghisu N; Da Settimo F; Natale G; Kastsiuchenka O; Duranti E; Virdis A; Vassalle C; La Motta C; Mugnaini L; Breschi MC; Blandizzi C; Del Taca M
J Pharmacol Exp Ther; 2007 Aug; 322(2):435-42. PubMed ID: 17488880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
